Key Stakeholders and the effect of their actions on the Financial Sustainability of the Pharmaceutical Company

1. Key Stakeholders and the effect of their actions on the Financial Sustainability of the Pharmaceutical Company Group A1

2. Overview The pharmaceutical companies The stakeholders Who are they? Responsibility over profit The stakeholders stages of involvement Who are the key stakeholders? What are their roles? Power & Interest How do these groups effect the financial sustainability of the company? Conclusion

3. Pharmaceutical Companies

4. Who are the stakeholders? Source:DimitrisDogramatzis, Pharmaceutical marketing: a practical guide (2001), p27-29

5. Responsibility over profit Trust Establishing trust among shareholders and social responsibility among customers Innovation Ensuring constant innovation and development Value Creating both financial and nonfinancial value

7. Key Opinion Leaders (i.e. Consultants)

9. Research & Development (Phase I to IV)

11. Health Provider (Doctor, Nurse & Hospitals)

12. Patient & General Public

13. Certain Institution (Insurance Companies)

15. Who are the key stakeholders? Power/Interest Matrix -Gardner, J.R., Rachlin, R. and Sweeny, H.W.A., Handbook of Strategic Planning (1986)

16. Financial Sustainability Organization being able to generate adequate profits while meeting operating expenditures.

17. Financial Viability of Pharmaceutical Industry Ethical contribution to sales Source: Reuters Business Insight (2003a: 104), company accounts and SEC filings

18. Industry Analysis (UK) TRADE FIGURES RETAIL PRICE FIGURES Source: The Association of the British Pharmaceutical Industry (ABPI Annual Review 2008 - Industry facts & figures)

19. Conclusion Key Stakeholders Crucial to the company Decisions makers Financial Sustainability Costs Short-Term Long-Term